Peer Review History
| Original SubmissionJune 16, 2019 |
|---|
|
PONE-D-19-17072 Multimorbidity and complex multimorbidity in Brazilian rural workers PLOS ONE Dear Dr. Salaroli, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In particular, please address the point made by Reviewer #1 on the lack of socio-demographic correlates. I suspect the reviewer is expecting to see multimorbidity occurring mainly in those with lower socio-economic status, and also those who are older. Please comment on whether there are special circumstances for the cohort studied that mask these factors. Please also provide more details on the sampling strategy and statistical procedures, in case this might be the result of a simple mistake. We would appreciate receiving your revised manuscript by Oct 24 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Siew Ann Cheong, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 1. Please include additional information regarding the semi-structured questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 2. Please provide further details regarding how participants were recruited. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In the present manuscript Petarli and colleagues aimed to estimate the prevalence of multimorbidity and complex multimorbidity in rural workers and their association with sociodemomographic, occupational, and clinical correlates. The article is quite interesting as it provides estimates based on a population with quite specific lifestyle and occupational exposure to specific agents (e.g. pesticides), which might require targeted interventions/public health policies. What I found quite important to highlight is that in the multivariable model, in contrast to previous literature, almost no socio-demographic correlates (with the exception of age, which is a well-established strong predictor of multimorbidity) remained significant, while all clinical ones were found associated with the likelihood of having multimorbidity and I would suggest authors to elaborate more on this (and possible explanations). Other points: - Introduction and discussion are sufficiently well-written but to make comparisons even more relevant the cited literature should be enriched with even more recent published papers on the epidmiology of multimorbidity (especially in western countries) - Further details on the sampling strategy should be provided. Authors provide a SS calculation to detect selected outcomes (which should also be expanded with additional information to allow reader to better understand and repeat calculations) but I doubt that this survey was originally based on this SS calculation, please explain and elaborate more on the sampling in general. Additionally, authors do no mention the use of survey weights: does this mean that non-respondent problem was encountered? - The authors adopt an empirical approach for the inclusion of covariates in the multirvariable models which is somehow in contrast with the current tendency to select covariates mostly by literature research. Please justify this approach Reviewer #2: General comments: Authors have highlighted a very pertinent issues on multimorbidity and its complexities. The overall article content is clear; however,it needs to be reviewed and copy-edited for English language to make language of the article clear, correct before re-submitting. Specific comments: 1. Abstract conclusion is not clear and need rephrasing for better clarity. 2. line 100-105: The sentences are confusing and not clear. It would be better to rewrite the sentences with more clarity. It is not clear what authors want to convey by saying "lack of standardization regarding the most effective way to diagnose this condition." 3. The study is based on data from "Condition of health and associated factors: a study in farmers of Espírito Santo - AgroSaúdES". As a part of better clarity it would be appropriate to provide a brief description of the parent study: how the sampling was done, how data were collected and what information collected in the parent study. 4. Line 120-121: Need rephrasing! 5. Sample size calculation: Authors have mentioned that they included 806 sample for their study which would provide 96.9% power to detect the outcome. This is not clear. Authors should provide a detail description of the sample size calculation in a separate section or within the section of study population. 6. It would be better to provide a more detail information on how and what information were collected under Anthropometric, hemodynamic and biochemical data. 7. line 157: what is the full form of RSI/WMSD 8. line no.170- The classification of Blood pressure level and not the "pressure level " 9. Line 197: lifestyle (smoking, physical activity, alcohol consumption)- How these lifestyle factors were elicited and examined? 10. line 206-208: Authors have categorised waist circumference based on WHO classification and termed it as without cardiovascular risk and increased cardiovascular risk. However, this WHO classification relates to metabolic risk rather than CVD risk. 11. Is there any other anthropometric measurements such as height and weight (BMI) were collected in the survey and if collected why authors have not included in the study. 12. Line 368: What are the types of diseases when you mentioned the word "disease" in this sentence? 13. References: a. Line 450: link not working b. References should be checked for uniformity in the formating style and journal names. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Raffaele Palladino Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Multimorbidity and complex multimorbidity in Brazilian rural workers PONE-D-19-17072R1 Dear Dr. Salaroli, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Siew Ann Cheong, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Authors have addressed all my comments. A very minor comment is that p value = 0.000 should be replaced with p value<0.0001 Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Raffaele Palladino Reviewer #2: No |
| Formally Accepted |
|
PONE-D-19-17072R1 Multimorbidity and complex multimorbidity in Brazilian rural workers Dear Dr. Salaroli: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Siew Ann Cheong Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .